Answers are grounded in this paper and cite their sources.
Background CYP1A1 is a gene involved in the high aryl hydrocarbon hydroxylase -inducible phenotype, which is a genetically-determined variation among individuals that has been associated with lung cancer risk. More specifically, CYP1A1 * 2B and * 4 polymorphisms have been associated with high susceptibility to lung cancer among cigarette smokers. Materials and methods: DNA was obtained from blood samples and we studied by PCR-RFLP the distribution of CYP1A1 * 2B (n=248) and * 4 (n=222) polymorphisms in healthy controls and 222 lung cancer patients from a Mexican population. Results Comparisons between groups showed an increased risk for lung cancer patients of * 2B/ * 2B (18%; OR 7.6; 95% CI 3.0–19.2) and * 4/ * 4 genotypes (15%; OR 11.45; 95% CI 2.19–59.85) compared to the control group (1% for * 2B/ * 2B and 4.4% for * 4/ * 4). A significant association between lung cancer and homozygous * 2B/ * 2B passive smokers and * 4/ * 4 ever (cigarettes) and passive smokers was also observed (p<0.05). Multivariate analysis revealed an increased risk for the * 2B/2B genotype (OR 6.83), as well as for * 4/ * 4 (OR 28.8). Conclusion The results of the study indicate a significant association between * 2B/ * 2B and * 4/ * 4 genotypes and the risk of developing lung cancer among Mexicans.
No takes yet. Share an insight, caveat, or question.
Gallegos‐Arreola et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: